Clinical and genetic risk factors for aromatase inhibitor-associated arthralgia in breast cancer survivors

Clinical and genetic risk factors for aromatase inhibitor-associated arthralgia in breast cancer survivors

Background: Arthralgia is a common and debilitating toxicity of aromatase inhibitors (AI) that leads to premature drug discontinuation. We sought to evaluate the clinical and genetic risk factors associated with AI-associated arthralgia (AIAA). Methods: We performed a cross-sectional study among pos...

Full description

Bibliographic Details
Main Authors: Sally A.D. Romero, H. Irene Su, Jaya Satagopan, Q. Susan Li, Christina M. Seluzicki, Annika Dries, Angela M. DeMichele, Jun J. Mao
Format: Article
Language:English
Published: Elsevier 2020-02-01
Series:Breast
Subjects:
Breast neoplasm
Aromatase inhibitor
Genetics
Arthralgia
Postmenopausal
Risk factors
Online Access:http://www.sciencedirect.com/science/article/pii/S0960977619305788

Internet

http://www.sciencedirect.com/science/article/pii/S0960977619305788

Similar Items